I need some sales if I'm going to stay in business.  Please place orders via the affiliate links on this web site.  It's the same price.  If you bookmark or type in the URL, I don't get credit for the sale.
QualityCounts.com    Comprehensive Anti-aging Research   Share

Add to Google
Home iHerb Int Antiaging Sys Prescriptions Life Extension Products Amazon.com Dr. Weil's Vitamin Advisor Contact
Anti-aging Newsletter Signup
 Newsletter Archive
 Newsletter via RSS Feed
 Research on Supplements
 Health Conditions
 Anti-aging Recommendations
 Insulin and Aging
 QualityCounts.com in Time
 Longevity Web Sites
 Drug Databases
 Longevity Affiliates:
 iHerb
 Int. Anti-aging Systems
 Life Extension Products
 Puritan's Pride
 Mozy Unlimited Backup
 Vitamin Shoppe
 DiabetesStore.Com
 The Karaoke Channel
 Medifast Diet
 Drugstore.com
 J & R Music
 Beauty.com
 Revival Soy Products
 Dr. Weil's Polaris productsicon
 BettyMills
 Vital Choice Seafood
 Love Scent Pheromones
 Online Prescriptions
 GreatSkin.com
 Overseas Pharmacies
 Other Neat Links

Welcome to the Quality Counts. For those health conscious consumers and medical professionals that are looking to purchase nutritional supplements, vitamins, herbs, learning about medications, losing weight, health food, low carbs, high protein nutrition, and exercise, you have come to the right place. Quality Counts serves both the medical practitioner and consumer interested in nutritional therapy and alternative medicine.

Home > Anti-aging Research > Policosanol

Policosanol/Octacosanol

Related Topics:

Recommendations:

News & Research:

Abstracts:

  • Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients - Adv Ther. 2011 Nov 21 - "containing berberine 500 mg, policosanol 10 mg, red yeast rice 200 mg, folic acid 0.2 mg, coenzyme Q10 2.0 mg, and astaxanthin 0.5 mg) or placebo ... There was a statistically significant reduction in total cholesterolemia (-20%), LDL-C (-31%), and insulin resistance (-10%) with nutraceutical treatment. No significant changes were detected for plasma high-density lipoprotein cholesterol (HDL-C). Furthermore, no statistical differences were found between baseline and end-study safety parameters. Medication compliance and tolerability were high" - Note: I’m been promoting synergy and talking lower doses of everything proven in specific areas like this for some time.
  • Effect of omega-3 and policosanol supplementation on attention and reactivity in athletes - J Am Coll Nutr. 2009 Aug;28 - "After 21 days of supplementation, subjects who received O3 + P showed a reduced reaction time and increased vigor sensation associated with a reduction of the negative states measured with the POMS test. Analysis of the event-related brain potentials showed a reduced latency of the movement-related brain macropotentials. In particular, the potentials recorded in the premotor period and motor period occurred earlier and the latency of EMG activation was reduced. In the third test, 21 days after the last O3 + P supplementation, the positive effects on the mood state persisted, while the reaction time, EMG, and brain potential latencies increased, although their values remained lower than in the first test. The placebo group did not show any significant differences in Tests 2 and 3 compared to Test 1 for either POMS or reactivity and brain potentials"
  • Policosanol is ineffective in the treatment of hypercholesterolemia: a randomized controlled trial - Am J Clin Nutr. 2006 Dec;84(6):1543-8 - "Policosanol does not alter the serum lipid profile over an 8-wk period in adults with mild hypercholesterolemia"
  • Lack of cholesterol-lowering efficacy of Cuban sugar cane policosanols in hypercholesterolemic persons - Am J Clin Nutr. 2006 Nov;84(5):1003-8 - "2-40 mg Cuban sugar cane policosanol (SCP) mixtures/d ... Present results show no beneficial effects of Cuban SCPs on lipid indicators in hypercholesterolemic persons and question the clinical usefulness of policosanol mixtures as cholesterol-lowering neutraceutical agents"
  • Wheat germ policosanol failed to lower plasma cholesterol in subjects with normal to mildly elevated cholesterol concentrations - Metabolism. 2004 Oct;53(10):1309-1314
  • Policosanol: Clinical pharmacology and therapeutic significance of a new lipid-lowering agent - Am Heart J 2002 Feb;143(2):356-65 - "At doses of 10 to 20 mg per day, policosanol lowers total cholesterol by 17% to 21% and low-density lipoprotein (LDL) cholesterol by 21% to 29% and raises high-density lipoprotein cholesterol by 8% to 15%"
  • Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study - Int J Clin Pharmacol Res 2001;21(1):43-57 - "although the tolerability profile remains excellent, according to the present results policosanol at a dose of 40 mg/day does not offer significant additional cholesterol-lowering efficacy over the 20 mg/day dose"
  • Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk - J Gerontol A Biol Sci Med Sci 2001 Mar;56(3):M186-92 - "After 6 weeks on a lipid-lowering diet, 179 patients randomly received a placebo or policosanol at doses of 5 followed by 10 mg per day for successive 12-week periods of each dose. Policosanol (5 and 10 mg/d) significantly (p < .001) reduced low-density lipoprotein cholesterol (LDL-C; 16.9% and 24.4%, respectively) and total cholesterol (TC; 12.8% and 16.2%, respectively), while significantly (p < .01) increasing (p < .001) high-density lipoprotein cholesterol (HDL-C) by 14.6% and 29.1%, respectively ... No serious adverse experiences occurred in policosanol patients (p < .01), compared with seven adverse experiences (7.9%) reported by placebo patients"
  • A long-term study of policosanol in the treatment of intermittent claudication - Angiology 2001 Feb;52(2):115-125 - "After 6 months of therapy, policosanol significantly increased (p < 0.01) the initial claudication distance from 125.9 +/- 8.7 m to 201.1 +/- 24.8 m and the absolute claudication distance from 219.5 +/- 14.1 m to 380.7 +/- 50.2 m. Both variables remained unchanged in the placebo group (p < 0.01). These effects did not wear off but improved after long-term therapy, so that final values were 333.5 +/- 28.6 m (initial claudication distance) and 648.9 +/- 54.1 m (absolute claudication distance); both significantly greater (p < 0.0001) than those obtained in the placebo group, which showed values of 137.9 +/- 21.8 m (initial claudication distance) and 237.7 +/- 28.1 m (absolute claudication distance), respectively"

Other possible policosanol suppliers:

Related Searches:

70419